TP53 and head and neck squamous cell carcinoma: HNSCC expressing the TP53 mutation is associated with a higher level of radioresistance compared to HNSCC wild type TP53, as demonstrated by Sandulache et al., the sensitivity to glycolytic inhibition being explained by the decrease in mitochondrial complex II and IV activity in cases expressing the TP53 mutation.